• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>St. Jude Medical

St. Jude Medical

St Jude Medical Inc STJ 3 Star

Last Price$65.27Day Change (%)-0.20%
Open Price$65.38Day Change ($)-0.13
Day Range64.81–65.7752-Week Range54.80–71.90

As of Wed 4/1/2015 5:52:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. New CHAMPION Data Show Significant Improvement in Survival Rates for Heart Failure Patients with Reduced Ejection Fraction

    New CHAMPION Data Show Significant Improvement in Survival Rates for Heart Failure Patients with Reduced Ejection Fraction

  2. Research and Markets: China Cardiovascular Devices Market 2015 - 2007 to 2014 and forecast till 2020

    Research and Markets: China Cardiovascular Devices Market 2015 - 2007 to 2014 and forecast till 2020

  3. Research and Markets: India Cardiac Rhythm Management Market Analysis 2015 - Size, Share, Growth, Trends and Forecast Through 2007 - 2020

    Research and Markets: India Cardiac Rhythm Management Market Analysis 2015 - Size, Share, Growth, Trends and Forecast Through 2007 - 2020

  4. Research and Markets: India Cardiac Catheters and Guidewires Market Analysis - Size, Share, Growth, Trends and Forecast Through 2007 - 2020

    Research and Markets: India Cardiac Catheters and Guidewires Market Analysis - Size, Share, Growth, Trends and Forecast Through 2007 - 2020

  5. Research and Markets: China Cardiac Catheters and Guidewires Market Analysis 2015 - 2020

    Research and Markets: China Cardiac Catheters and Guidewires Market Analysis 2015 - 2020

  6. Research and Markets: China Cardiac Rhythm Management Market Analysis 2015-2020

    Research and Markets: China Cardiac Rhythm Management Market Analysis 2015-2020

  7. Research and Markets: Japan Heart Valve and Repair Market Analysis 2015-2020

    Research and Markets: Japan Heart Valve and Repair Market Analysis 2015-2020

  8. Our Outlook for the Credit Markets

    Widening investment-grade credit spreads and rising interest rates lead to losses.

  9. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

  10. Together We Stand, Divided We Fall?

    Each succeeding bailout entangles the global financial system even further.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.